An anthrone-based Kv7.2/7.3 channel blocker with improved properties for the investigation of psychiatric and neurodegenerative disorders
Jacob D. Porter, Oscar L. Vivas-Rodriguez, C. David Weaver, Eamonn J. Dickson, Abdulmohsen Alsafrana, Elliot DiMilo, Leggy A. Arnold and Chris Dockendorff
Bioorganic and Medicinal Chemistry Letters 2019, 29(23), 126681.

The Parmodulin NRD-21 is an Allosteric Inhibitor of PAR1 Gq Signaling with Improved Anti-Inflammatory Activity and Stability
Disha M. Gandhi, Ricardo Rosas, Jr., Eric Greve, Kaitlin M. Kentala, N'Guessan D.-R. Diby, Vladyslava A. Snyder, Allison Stephans, Teresa H. Y. Yeung, Saravanan Subramaniam, Khia E. Kurtenbach, Elliot DiMilo, Leggy A. Arnold, Hartmut Weiler and Chris Dockendorff
Bioorganic and Medicinal Chemistry 2019, 27(17), 3788-3796.

Design and evaluation of heterobivalent PAR1–PAR2 ligands as antagonists of calcium mobilization
Mark Majewski, Disha Gandhi, Ricardo Rosas, Revathi Kodali, Leggy A. Arnold, Chris Dockendorff
ACS Medicinal Chemistry Letters 2018, 10, 121-126.

Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays
Sourav Mukherjee, Alicia M. Hanson, William R. Shadrick, Jean Ndjomou, Noreena L. Sweeney, John J. Hernandez, Diana Bartczak, Kelin Li, Kevin J. Frankowski, Julie A. Heck, Leggy A. Arnold, Frank J. Schoenen and David N. Frick*
Nucleic Acids Res. 2012, 40(17), 8607-8621.

Inhibition of a viral enzyme by a small-molecule dimer disruptor
Tina Shahian, Gregory M. Lee, Ana Lazic, Leggy A. Arnold, Priya Velusamy, Christina M. Roels, R. Kiplin Guy & Charles S Craik*
Nat Chem Biol. 2009, 5, 640-6.

*corresponding authors